Infliximab

• IXIFI 100 MG I.V. INFUZYONLUK COZELTI HAZIRLAMADA KULLANILACAK KONSANTRE ICIN TOZkode batang: 8681308771018
• REMICADE 100 MG IV INFUZYONLUK COZELTI HAZIRLAMADA KULLANILACAK KONSANTRE ICIN TOZ 1 FLAKONkode batang: 8699593791031
• REMICADE 100 MG KONSANTRE IV INFUZYON COZELTISI HAZIRLAMAK ICIN LIYOFILIZE TOZ ICEREN 1 FLAKONkode batang: 8699636790380
• REMSIMA 100 MG I.V. INFUZYON COZELTISI HAZIRLAMAK ICIN LIYOFILIZE TOZ ICEREN 1 FLAKONkode batang: 8680614140112
• REMSIMA 120 MG/ML SC ENJEKSIYONLUK COZELTI ICEREN KULLANIMA HAZIR KALEM (2 ADET)kode batang: 8680614140167

Tidak ada catatan makanan tercatat untuk zat aktif ini.

• AcipimoxMAYOR

  Mengonsumsi Infliximab bersama Acipimox dapat meningkatkan risiko atau keparahan miopati (penyakit otot) ve rabdomiolisis ve mioglobinuria.

  Tampilan ahli

  The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Infliximab is combined with Acipimox.

• Alendronic acidMAYOR

  Mengonsumsi Infliximab bersama Alendronic acid dapat meningkatkan risiko atau keparahan miopati (penyakit otot) ve rabdomiolisis ve mioglobinuria.

  Tampilan ahli

  The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Infliximab is combined with Alendronic acid.

• Aluminium clofibrateMAYOR

  Mengonsumsi Infliximab bersama Aluminium clofibrate dapat meningkatkan risiko atau keparahan miopati (penyakit otot) ve rabdomiolisis ve mioglobinuria.

  Tampilan ahli

  The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Infliximab is combined with Aluminium clofibrate.

• Amphotericin BMAYOR

  Mengonsumsi Infliximab bersama Amphotericin B dapat meningkatkan risiko atau keparahan miopati (penyakit otot) ve rabdomiolisis ve mioglobinuria.

  Tampilan ahli

  The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Infliximab is combined with Amphotericin B.

• BaclofenMAYOR

  Mengonsumsi Infliximab bersama Baclofen dapat meningkatkan risiko atau keparahan miopati (penyakit otot) ve rabdomiolisis ve mioglobinuria.

  Tampilan ahli

  The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Infliximab is combined with Baclofen.

• BezafibrateMAYOR

  Mengonsumsi Infliximab bersama Bezafibrate dapat meningkatkan risiko atau keparahan miopati (penyakit otot) ve rabdomiolisis ve mioglobinuria.

  Tampilan ahli

  The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Infliximab is combined with Bezafibrate.

• BumetanideMAYOR

  Mengonsumsi Infliximab bersama Bumetanide dapat meningkatkan risiko atau keparahan miopati (penyakit otot) ve rabdomiolisis ve mioglobinuria.

  Tampilan ahli

  The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Infliximab is combined with Bumetanide.

• CaptoprilMAYOR

  Mengonsumsi Infliximab bersama Captopril dapat meningkatkan risiko atau keparahan miopati (penyakit otot) ve rabdomiolisis ve mioglobinuria.

  Tampilan ahli

  The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Infliximab is combined with Captopril.

• CarbimazoleMAYOR

  Mengonsumsi Infliximab bersama Carbimazole dapat meningkatkan risiko atau keparahan miopati (penyakit otot) ve rabdomiolisis ve mioglobinuria.

  Tampilan ahli

  The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Infliximab is combined with Carbimazole.

• CimetidineMAYOR

  Mengonsumsi Infliximab bersama Cimetidine dapat meningkatkan risiko atau keparahan miopati (penyakit otot) ve rabdomiolisis ve mioglobinuria.

  Tampilan ahli

  The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Infliximab is combined with Cimetidine.